Interstitial granulomatous dermatitis associated with gabapentin

Dermatitis

Volumn 25, Issue 6, 2014, Pages 374-375

  Georgesen, Corey ^a   McDonough, Patrick ^a   Cruz, Ponciano ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN; HYDROCORTISONE; LISINOPRIL; METFORMIN; PREDNISONE; 4 AMINOBUTYRIC ACID; AMINE; ANALGESIC AGENT; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE;

ADULT; CASE REPORT; DERMATITIS; DISEASE DURATION; DRUG SAFETY; DRUG WITHDRAWAL; HUMAN; INTERSTITIAL GRANULOMATOUS DERMATITIS; LETTER; MALE; MIDDLE AGED; PAPULE; PRIORITY JOURNAL; RASH; SKIN BIOPSY; DRUG ERUPTIONS; PATHOLOGY;

AMINES; ANALGESICS; CYCLOHEXANECARBOXYLIC ACIDS; DRUG ERUPTIONS; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED;

EID: 84928169307     PISSN: 17103568     EISSN: 21625220     Source Type: Journal    
DOI: 10.1097/DER.0000000000000080     Document Type: Letter

References (4)

1. Alcaftadine prescribing information. Available at: http://www.allergan.com/assets/pdf/lastacaft-pi.pdf. Accessed April 30, 2014.
2. Andersen KE. Reproducibility of the chamber scarification test. Contact Dermatitis 1996;34(3):181-184.
3. Frosch PJ, Kligman AM. The chamber-scarification test for irritancy. Contact Dermatitis 1976;2(6):314-324.
4. Riedl B, Reitmeier G, Heese A, et al. Type IV allergy to components of ophthalmologic drugs [in German; translated via Google translator]. Klin Monbl Augenheilkd 1991;198(4):251-254.